baber/WOPTO huggingface dataset:
Patent JP-4158092-B2 (JP)
IPC: H04N13/02
Filed: 2002-09-06
Granted: 2008-10-01
Abstract: <P>PROBLEM TO BE SOLVED: To provide an adapter capable of accurately attaching an optical attachment (stereoscopic image capturing device) to a photographing device such as a video camera, and an attaching mechanism for the stereoscopic image capturing device by using the adapter.  <P>SOLUTION: The adapter for photographing the stereoscopic image 30 used to attach the stereoscopic image capturing device (optical attachment) 31 to the photographing device such as a digital camera 37 has a position regulating means (the inner peripheral surfaces 42A and 42B of a ring part 33 and the projected line part 50 of a fixed plate part 38) for regulating a mounting position on the photographing device and is constituted to be detachably mounted on the housing 49 of the photographing device by the fitting of irregularities. The attaching mechanism for detachably supporting the device 31 on the adapter 30 by the fitting of the irregularities is provided.  <P>COPYRIGHT: (C)2004,JPO
Patent JP-3991267-B2 (JP)
IPC: G01N21/77
Filed: 2002-10-08
Granted: 2007-10-17
Abstract: The present invention relates to a technique for analyzing the concentration of a specific component in a sample liquid, such as a method for analyzing a sample. The analyzing method includes a first detection step for irradiating light from a light source (50) onto a reaction system to detect a response from the reaction system (56) as a first detection result. The reaction system contains a sample liquid and a reagent. The method also includes a second detection step for irradiating light onto a reference board (54) to detect a response from the reference board as a second detection result. The response from the reference board under light irradiation is dependent on wavelength. The method further includes a calculation step for calculating the concentration of the specific component in the sample liquid based on the first and second detection results. <IMAGE>
Patent JP-4355488-B2 (JP)
IPC: H01L21/673
Filed: 2002-12-25
Granted: 2009-11-04
Abstract: <P>PROBLEM TO BE SOLVED: To provide a molecular contamination monitoring system capable of tracing molecular contamination states at product levels over the whole manufacturing processes.  <P>SOLUTION: The molecular contamination monitoring system comprises a process device for applying the processing of a prescribed manufacturing process to material substrates, a storing/carrying container detachably attached to the process device and capable of storing/carrying the material substrates, a molecular contamination sensor arranged in the storing/carrying container and having a quartz oscillator and an output circuit for outputting the frequency information of the quartz oscillator, and a reader for reading out the frequency information from the sensor and the identification information of the sensor when the storing/carrying container is attached to the process device. Since the oscillation frequency of the quartz oscillator is changed by adhesion of contaminated molecules to the quartz oscillator, the contaminated state of the material substrates in the storing/carrying container can be monitored on the basis of the frequency information and the identification information.  <P>COPYRIGHT: (C)2004,JPO
Patent JP-4107082-B2 (JP)
IPC: G09F13/20
Filed: 2002-12-26
Granted: 2008-06-25
Abstract: <P>PROBLEM TO BE SOLVED: To provide an illumination device that directs glass with desired colors in a mosaic state.  <P>SOLUTION: This illumination device is composed of an ultraviolet ray light source having an ultraviolet ray LED arranged so as to introduce the ultraviolet ray into the inside of a plate member while a plate state part containing a fluorescent material composed of an inorganic or organic material is coupled to a coupling part composed of a transparent silicon resin and forms one sheet of the plate member, and the fluorescent material of the plate state part is excited by light from the ultraviolet ray light source to emit the light. By connecting the plate members with coupling materials of various shapes for forming, the illumination device of a desired design is realized.  <P>COPYRIGHT: (C)2004,JPO&NCIPI
Patent JP-4733335-B2 (JP)
IPC: G01N33/577
Filed: 2001-08-28
Granted: 2011-07-27
Abstract: The present invention provides an agglutination immunoassay, wherein the agglutination of insoluble carrier particles such as latex are stabilized and uniformized to give good reproducibility, and a reagent therefor. In the agglutination immunoassay which comprises allowing an antigenic substance in a sample to bind to insoluble carrier particles carrying substantially neither antigens nor antibodies thereon, and allowing an antibody or an antibody complex which reacts specifically to the antigenic substance to bind to the antigenic substance to give a selective agglutination of the insoluble carrier particles, a homopolymer prepared by polymerization of a monomer such as 2-methacryloyloxyethyl phosphorylcholine having a phosphorylcholine group and a vinyl group, or a copolymer prepared by polymerization of a monomer having a phosphorylcholine group and a vinyl group, with a monomer having a vinyl group such as n-butyl methacrylate is used.
Patent JP-4031362-B2 (JP)
IPC: C09K23/00
Filed: 2001-10-23
Granted: 2008-01-09
Abstract: A particulate composition comprising particles having a core comprising a hydrophobic polymer within a shell, characterised in that the shell comprises a semi-permeable membrane. Particulate composition can be used for making a stable dispersion of particles uniformly distributed throughout a first hydrophobic liquid, wherein the particles comprise a core within a shell and the core comprises a hydrophobic polymer into has been imbibed a second hydrophobic liquid, Compositions can be used to encapsulate active substances and may be used in sustained release mechanisms.
Patent JP-4246490-B2 (JP)
IPC: A61P25/22
Filed: 2001-11-22
Granted: 2009-04-02
Abstract: This invention relates to morpholine derivatives of formula (I) and their use as antagonists of orexin receptors.
Patent JP-3986963-B2 (JP)
IPC: G11C27/02
Filed: 2001-12-11
Granted: 2007-10-03
Abstract: An electronic circuit comprising a sample and hold circuit (S/H) for sampling and temporarily holding an input data signal (Ui, Ii), comprising means (S; TS) for the sampling of a data voltage (U1) which corresponds to the input data signal (Ui, Ii), a capacitive element (C1) for temporarily holding the sampled voltage (UC), and means (CPR) for compressing the voltage range of the data voltage (U1) which is to be sampled. The electronic circuit is further provided with expansion means (EXP) for converting the sampled voltage (UC1) into a sampled output data signal (I0) in a manner such that it corresponds linearly to the input data signal (Ui, Ii). This is achieved, for example, by using a first field effect transistor (T1) for the compression means (CPR) and a second field effect transistor (T2) for the expansion means (EXP). The gate-source voltage of the first field effect transistor (T1) forms the data voltage (U1) which is compressed since the drain-source current of the first field effect transistor (T1) is linear with respect to the input data signal (Ui, Ii). The first (T1) and second (T2) field effect transistors in fact form a sample and hold current mirror. Thus, though the output current of the sample and hold current mirror is approximately linear with respect to the input current, the output current is a sampled version of the input current.
Patent JP-4147109-B2 (JP)
IPC: A61K9/00
Filed: 2002-01-17
Granted: 2008-09-10
Abstract: The present invention has the object to dehydrate hydrous matters without denaturing or deteriorating them by using a dehydrating agent comprising an anhydrous cyclotetrasaccharide, and provides a dehydrating agent comprising the cyclotetrasaccharide; a method for dehydrating hydrous matters through a step of incorporating, contacting or coexisting the cyclotetrasaccharide into, with, or in the hydrous matters; and dehydrated products obtainable thereby. <IMAGE>
Patent JP-4135174-B2 (JP)
IPC: B60R21/01
Filed: 2002-05-25
Granted: 2008-08-20
Abstract: A safety belt roll-up mechanism is provided, and includes a force limitation device that operates in a multi-stage manner and has a two-stage torque rod and a pyrotechnically operating switching device that couples the torque rod, in various clamping lengths, with a belt shaft. The extent of the belt strap unwound from the belt shaft is utilized for actuation of the force limitation device. A ratchet wheel is connected to the belt shaft via a reduction gear mechanism. A portion of the periphery of the ratchet wheel has a toothing for engaging the reduction gear mechanism. A further portion of the periphery of the ratchet wheel has a switching contour that rests against a contact pin of an electric switch. The switching contour has a profile that effects the connection or disconnection of the switching device for the torque rod.
Patent JP-4343551-B2 (JP)
IPC: G10L25/51
Filed: 2003-02-25
Granted: 2009-10-14
Abstract: The object of this invention is to properly acquire music data from a CD to one's own memory via a network instead of by CD ripping, even when the CD is a so-called CCCD having copyright protection information for preventing illegal copying. When an automobile-AV apparatus acquires TOC information that corresponds to music data recorded on a CD and then records the music data that is recorded on the CD on to a HD, it comprises an HD recording unit that sends the acquired TOC information to a service server via a network, and then receives the corresponding information that is related to the music data and that is sent from the service server and records the received corresponding information on to the HD.
Patent JP-4087321-B2 (JP)
IPC: C08J3/12
Filed: 2003-09-17
Granted: 2008-05-21
Abstract: The present invention provides polyvinyl alcohol based (PVA) whose solubility in water varies with a small temperature change to a sufficiently great degree. In manufacturing a polyvinyl alcohol based polymer by: progressing a transesterification reaction of a polyvinyl ester based polymer with alcohol in a liquid reaction mixture including the polyvinyl ester based polymer, the alcohol, and a basic compound; precipitating the polyvinyl ester based polymer, at least a part of which has been transesterified with the alcohol, out of the liquid reaction mixture; and further progressing the transesterification reaction in the liquid reaction mixture including the polyvinyl ester based polymer that has precipitated, the liquid reaction mixture has a temperature of 75 DEG C to 150 DEG C when the polyvinyl ester based polymer, at least a part of which has been transesterified, starts precipitating.
Patent JP-4001859-B2 (JP)
IPC: A61F2/30
Filed: 2003-11-17
Granted: 2007-10-31
Abstract: An intervertebral disk arthroplasty device adapted to replace a disk between a first vertebra and a second vertebra in the spine, said arthroplasty device comprising a first member having a first joint surface, a top surface opposite said first joint surface, a first posterior end and a first anterior end; a second member having a second joint surface facing said first joint surface, a bottom surface opposite said second joint surface, and second posterior and anterior ends juxtaposed with corresponding ones of said first posterior and anterior ends; a first insert cup having a first receiving surface for receiving said top surface, and a first engaging surface opposite said first receiving surface for engaging the first vertebra; a second insert cup having a second receiving surface for receiving said bottom surface, and a second engaging surface opposite said second receiving surface for engaging the second vertebra; and retaining ribs disposed on each of said first and second engaging surface and extending parallel with said anterior and posterior ends of said first and second members, said retaining ribs being configured to permit movement of the disk arthroplasty device in a first direction and to resist movement of said disk arthroplasty device in an opposite direction.
Patent JP-4125672-B2 (JP)
IPC: C07B61/00
Filed: 2002-06-17
Granted: 2008-07-30
Abstract: Novel halophenyl derivatives of the general formula (I), wherein R<SUP>1 </SUP>is halogen, a leaving group or 1H-1,2,4-triazol-1-yl and R<SUP>2 </SUP>is ethynyl or carboxy, X<SUP>1 </SUP>is halogen and X<SUP>2 </SUP>and X<SUP>3 </SUP>are each independently hydrogen or halogen, and their manufacture are described. They are intermediates for manufacturing azole derivatives of the general formula (V) which are valuable medicaments useful for treating systemic mycoses.
Patent JP-4430394-B2 (JP)
IPC: D06P3/10
Filed: 2002-11-28
Granted: 2010-03-10
Abstract: The present invention relates to reactive dyes of the general formula (1) where X<SUP>1</SUP>, X<SUP>2</SUP>, R, M, m and n are each as defined in claim 1, processes for their preparation and also their use for dyeing and printing hydroxyl- and/or carboxamido-containing materials.
Patent JP-4111918-B2 (JP)
IPC: C10M163/00
Filed: 2002-09-30
Granted: 2008-07-02
Abstract: Disclosed herein is a composition comprising:(A) a lubricant, and(B) at least one 1,3,4-oxadiazole compound of the formula:whereinwherein R1 is selected from the group consisting of hydrogen, linear or branched alkyl, alkenyl, alkaryl, aryl, alkyl ether, and alkyl ester;R2, R3, and R4 are independently selected from the group consisting of hydrogen, linear or branched alkyl, alkenyl, alkaryl, and aryl; andany alkyl moiety can optionally contain within it oxygen ether, ester, or amide groups.
Patent JP-4470219-B2 (JP)
IPC: C07D217/22
Filed: 2003-02-20
Granted: 2010-06-02
Abstract: The present invention relates to the following phenylalanine derivatives or analogues thereof having an antagonistic activity to  alpha 4 integrin and therapeutic agents for various diseases concerning  alpha 4 integrin. <CHEM>
Patent JP-4493340-B2 (JP)
IPC: A61P25/28
Filed: 2002-12-10
Granted: 2010-06-30
Abstract: This invention discloses 1alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat immune disorders in humans as well as renal osteodystrophy.
Patent JP-4763291-B2 (JP)
IPC: C12N15/09
Filed: 2003-10-01
Granted: 2011-08-31
Abstract: The present invention provides a ligand isolated from  Moraxella catarrhalis  outer membrane protein which binds to CEACAM receptors, said ligand comprising a receptor binding domain comprising an amino acid sequence selected from the group disclosed, or a fragment, homologue, functional equivalent, derivative, degenerate or hydroxylation, sulphonation or glycosylation product or other secondary processing product thereof.  The invention also provides medicaments and vaccines comprising said ligand, and their use in the treatment or prophylaxis of infection. Also provided is a screening method for the identification of novel therapeutic compounds.
Patent JP-4145877-B2 (JP)
IPC: H02H9/04
Filed: 2003-10-02
Granted: 2008-09-03
Abstract: The overvoltage protection mechanism has first and second electrodes (12,18) electrode connections with connection planes (16,20). A third electrode (22) provides arc switching in an arc extinction chamber (30). An electrical dipole (36) is connected to the arc switch and has a resistance varying non linearly with voltage applied. The resistance is raided prior to arc passage and lowered above this level.
Patent JP-4660199-B2 (JP)
IPC: A61K31/497
Filed: 2003-12-17
Granted: 2011-03-30
Abstract: The invention concerns substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine having neurokinin antagonistic activity, in particular NK<SUB>1 </SUB>and NK<SUB>1</SUB>/NK<SUB>3</SUB>-antagonistic activity, their preparation, compositions comprising them and their use as a medicine, in particular for the treatment of schizophrenia, emesis, anxiety, depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pain, neurogenic inflammation, asthma, micturition disorders such as urinary incontinence and nociception. The compounds according to the invention can be represented by general Formula (I) and comprises also the pharmaceutically acceptable acid or base addition salts thereof, the stereochemically isomeric forms thereof, the N-oxide form thereof and prodrugs thereof, wherein all substituents are defined as in Claim 1. In view of their capability to antagonize the actions of tachykinins by blocking the neurokinin receptors, and in particular antagonizing the actions of substance P by blocking the NK receptors, the compounds according to the invention are useful as a medicine, in particular in the prophylactic and therapeutic treatment of tachykinin-mediated conditions, such as, for instance CNS disorders, in particular depression, anxiety disorders, stress-related disorders, sleep disorders, cognitive disorders, personality disorders, schizoaffective disorders, eating disorders, neurodegenerative diseases, addiction disorders, mood disorders, sexual dysfunction, pain and other CNS-related conditions; inflammation; allergic disorders; emesis; gastrointestinal disorders, in particular irritable bowel syndrome (IBS); skin disorders; vasospastic diseases; fibrosing and collagen diseases; disorders related to immune enhancement or suppression and rheumatic diseases and body weight control.
Patent JP-4739763-B2 (JP)
IPC: A61P11/06
Filed: 2003-12-16
Granted: 2011-08-03
Abstract: Isolated human monoclonal antibodies which bind to IL-8 (e.g., human IL-8) are disclosed. The human antibodies can be produced in a hybridoma, transfectoma or in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals, hybridomas, and transfectomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
Patent JP-4904000-B2 (JP)
IPC: G02B6/12
Filed: 2003-12-05
Granted: 2012-03-28
Abstract: A tapered waveguide improves insertion loss occurring at the slab/waveguide interface of an optical array waveguide grating (AWG). The tapered waveguide has two segments. The first segment decreases from a first thickness, nearest the slab of the AWG to a second thickness moving away from the slab. The second segment has a substantially constant or uniform thickness equal to the second thickness of the first segment. The second segment may also have a swallowtail shape comprising a forked end having two sidewalls tapered back towards the first segment. Light that would otherwise be lost at the slab/waveguide interface is instead captured by the tapered waveguide which laterally channels the light back into the waveguides thus mitigating insertion loss.
Patent JP-4714486-B2 (JP)
IPC: A24B3/18
Filed: 2005-03-11
Granted: 2011-06-29
Abstract: The method involves directly conveying tobacco stream into the detection area of a foreign material detection laser (20) via compressed air (11). Foreign materials (17) in the tobacco stream are identified by the foreign material detection laser based on at least one characteristic. The detected foreign materials are removed from the tobacco stream.
Patent JP-4258481-B2 (JP)
IPC: F24F1/00
Filed: 2005-03-16
Granted: 2009-04-30
Abstract: <P>PROBLEM TO BE SOLVED: To achieve quick cooling or heating in starting a system in the air conditioning system composed of a latent heat load treating system having an adsorption heat exchanger and mainly treating indoor latent heat load, and a sensible heat load treating system having an air heat exchanger and mainly treating indoor sensible heat load.  <P>SOLUTION: This air conditioning system 1 comprises latent heat system use-side refrigerant circuits 10a, 10b and sensible heat system use-side refrigerant circuits 10c, 10d. The latent heat system use-side refrigerant circuits 10a, 10b have the adsorption heat exchangers 22, 23, 32, 33 provided with adsorbent on their surfaces. The sensible heat system use-side refrigerant circuits 10c, 10d have the air heat exchangers 42, 52 and perform heat exchange between the refrigerant and the air. In this air conditioning system 1, the air after heat exchange by the air heat exchangers 42, 52 is supplied indoors in starting the system, and the outdoor air is not allowed to pass through the adsorption heat exchangers 22, 23, 32, 33.  <P>COPYRIGHT: (C)2006,JPO&NCIPI
Patent JP-4547288-B2 (JP)
IPC: H04B10/27
Filed: 2005-03-17
Granted: 2010-09-22
Abstract: A network includes multiple nodes interconnected to form a ring topology. These nodes support data transmissions over the network using tokens. To send and receive data over the network, nodes may process control messages. A node can receive a first token (82, 84) authorizing transmission on one of multiple data channels, generate a transmission control message (104) identifying a destination node and the authorized data channel, and communicate (106) the transmission control message to a next node. The node can also communicate a second token to the next node authorizing secondary transmissions on the authorized data channel, transmit data on the authorized data channel after communicating the transmission control message, and communicate the first token to the next node after communicating the second token to the next node.
Patent JP-4008454-B2 (JP)
IPC: H04B10/18
Filed: 2005-04-14
Granted: 2007-11-14
Abstract: An apparatus for measuring a set of frequency-resolved states of polarization (SOP) of an optical signal includes a local oscillator (LO), a polarization scrambler, a coupler for mixing the polarization-scrambled signal with the optical signal to produce a heterodyned signal with a radio frequency (RF) component, and an analyzer for passing a fixed polarization component and resolving the polarization and frequency from the RF component. The apparatus is used for measuring, monitoring or compensating the polarization mode dispersion (PMD) in a working channel of an optical telecommunication system. A method for measuring frequency-resolved SOP of an optical signal includes tuning and polarization-scrambling a local oscillator (LO), mixing the scrambled LO with the optical signal, and resolving the RF signal in frequency and polarization. The method is applied to measure and monitor PMD in a working optical channel, and to dynamically compensate for the PMD. <IMAGE>
Patent JP-4197180-B2 (JP)
IPC: G01N33/564
Filed: 2005-06-29
Granted: 2008-12-17
Abstract: The present invention provides a method for the measurement capable of measuring an endocrine substance such as feline insulin in an analyte of an animal such as feline or the like with high accuracy, rapidity and brevity.  The method for the measurement of the endocrine substance in the analyte according to the present invention comprises pre-treating the analyte derived from the animal such as feline or the like by removing an autoantibody bound to the endocrine substance present in the analyte therefrom and measuring the endocrine substance in the pre-treated analyte. Further, the present invention can measure a value of the autoantibody bound to the endocrine substance in the analyte. In addition, the present invention allows a diagnosis and treatment of diseases associated with the endocrine substance by measuring the autoantibody value of the endocrine substance in the analyte.